Mm. Almugeiren et al., COAGULOPATHY OF CHILDHOOD NEPHROTIC SYNDROME - A REAPPRAISAL OF THE ROLE OF NATURAL ANTICOAGULANTS AND FIBRINOLYSIS, Haemostasis, 26(6), 1996, pp. 304-310
In an attempt to characterise further the coagulopathy of childhood ne
phrotic syndrome, this study concentrates on simultaneous measurements
of the natural anticoagulants [antithrombin III (ATIII), proteins C a
nd S] and the fibrinolytic factors, tissue plasminogen activator (tPA)
and plasminogen activator inhibitor (PAI). The study groups consisted
of 41. children (ages ranging from 2 to 14 years; median 7.1) in the
relapse of nephrosis and 48 children (ages ranging from 3 to 14 years;
median 7.6) in remission. The results obtained were compared with nor
mal values obtained in healthy age- and sex-matched controls (n = 103)
. During relapse, there was a marked increase in the plasma level of f
ibrinogen, protein C, and protein S and reduced plasma ATIII level; tP
A level was similar to control but PAI level exhibited a significant r
eduction. During remission, the protein C level either remained elevat
ed or increased further, but some decreased. Protein S and plasma ATII
I level normalised. The fibrinolytic activator tPA dropped slightly bu
t the PAI level remained significantly below control levels. We conclu
de that in the relapse of childhood nephrosis, despite the existence o
f a significant prothrombotic tendency as featured by hyperfibrinogena
emia and markedly reduced ATIII level, the simultaneous elevation of t
he natural anticoagulant, protein C level and enhanced fibrinolysis th
at persist until the remission phase, seem to be major preventive mech
anisms guarding nephrotic children against thromboembolic phenomena.